BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 17284895)

  • 1. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
    Rodrigues AS; Almeida M; Fonseca I; Martins M; Carvalho MJ; Silva F; Correia C; Santos MJ; Cabrita A
    Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients.
    Sawai A; Ito Y; Mizuno M; Suzuki Y; Toda S; Ito I; Hattori R; Matsukawa Y; Gotoh M; Takei Y; Yuzawa Y; Matsuo S
    Nephrol Dial Transplant; 2011 Jul; 26(7):2322-32. PubMed ID: 21098014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent.
    Selgas R; del Peso G; Bajo MA; Molina S; Cirugeda A; Sánchez-Tomero JA; Castro MJ; Castro MA; Vara F
    J Nephrol; 2001; 14(4):270-4. PubMed ID: 11506249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between VEGF receptors and baseline peritoneal transport status in new peritoneal dialysis patients.
    Zhang AH; Wang G; Zhang DL; Zhang QD; Liu S; Liao Y; Yin Y; Liu WH
    Ren Fail; 2012; 34(5):582-9. PubMed ID: 22563920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.
    Szeto CC; Law MC; Wong TY; Leung CB; Li PK
    Am J Kidney Dis; 2001 Feb; 37(2):329-36. PubMed ID: 11157374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
    Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
    Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.
    Sezer S; Elsurer R; Afsar B; Arat Z; Ozdemir NF; Haberal M
    Nephron Clin Pract; 2007; 107(4):c156-62. PubMed ID: 17957127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
    van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
    Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study.
    Martikainen T; Ekstrand A; Honkanen E; Teppo AM; Grönhagen-Riska C
    Scand J Urol Nephrol; 2005; 39(5):410-6. PubMed ID: 16257844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.